AI/ML Innovations' NeuralCloud Partners with Etisense for Enhanced ECG Analysis

AI/ML Innovations Inc. has announced that its subsidiary, NeuralCloud Solutions Inc., has signed an agreement with Etisense SAS. The partnership aims to integrate NeuralCloud's MaxYield™ technology to improve ECG labeling and analysis in animal research models. Etisense specializes in non-invasive telemetry and data analysis for preclinical research.

The collaboration will focus on using MaxYield™ with Etisense's LASA software, initially for large-animal models and potentially expanding to small-animal models. Etisense will maintain its platform and customer interactions, while NeuralCloud provides the AI-powered MaxYield™ engine.

The goal is to enhance the efficiency of ECG data processing and labeling for pharmacology and toxicology studies. NeuralCloud retains all intellectual property rights to MaxYield™, and the agreement is non-exclusive. The initiative marks NeuralCloud's expansion into the preclinical research sector.